US Patent 7459455 Pyrimidine compounds
Patent 7459455 was granted and assigned to Smithkline Beecham Limited on December, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Douglas McCord Sammond0
James Marvin Veal0
Kristen Elizabeth Nailor0
Mui Cheung0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+282 characters)
Article
Patent abstract
Pyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07459455 Pyrimidine compounds US Patent 7459455 Pyrimidine compounds
Infobox
Patent Number
074594550
Patent Number
74594550
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074594550
Date of Patent
December 2, 2008
0Patent Application Number
105038740
Date Filed
February 7, 2003
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07459455 Pyrimidine compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07459455
Date of patent
December 2, 2008
Patent application number
10503874
Date Filed
February 7, 2003
Patent primary examiner
Find more entities like US Patent 7459455 Pyrimidine compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
